Kalvista Pharmaceuticals Inc
KALV
$27.00+0.00%
End of day · as of Oct 13, 2026, 7:15 AM ET
Mkt cap
$1.44B
EV/Sales
26.6
P/E ratio
N/A
FY2025 Revenue
$49.08M
EPS (9mo ended 2025-09-30)
$-2.97
Gross Margin (FY2025)
93.72%
Profit Margin (FY2025)
-223.16%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Latest reported KALV revenue for 2025-12-31 was $49.1M. Net income was -$109.5M. Revenue was down 1.8% from 2024-04-30 to 2025-12-31. KALV currently screens at market cap $1.44B.
Use this KALV research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KALV income, balance, and cash tables.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company in the Healthcare sector.
Latest cached Kalvista Pharmaceuticals Inc (KALV) revenue for Dec 31, 2025 was $49.1M. Net income was -$109.5M. Statements: https://lician.com/financials/kalv
Kalvista Pharmaceuticals Inc (KALV) market capitalization is $1.44B on the latest cached snapshot.
Kalvista Pharmaceuticals Inc (KALV) cached previous close $27.00; day range $26.98 – $27.00; volume 4,262,878. Session quote: https://lician.com/quote/kalv
Kalvista Pharmaceuticals Inc (KALV) latest cached earnings event is "KALV earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached KALV filing is 8-K · Jan 8, 2026. Filings: https://lician.com/sec/kalv